Science & Enterprise logo
Science for business people. Enterprise for scientists.
  • Trial Shows Sealant Gel Closes Spinal Surgery Wounds

    A clinical trial led by researchers at University of California at Davis found a gel that creates a watertight seal to close surgical wounds, sealed spinal wounds 100 percent of the time. The UC Davis team reported their findings in the online issue of the journal Spine (paid subscription required). The trial, funded by the…

  • Calendar Blister Packs Shown to Help Medication Adherence

    A study of drug packaging indicates that calendar blister packaging with days or dates printed on the card under the individual dose helps patients keep to the prescribed schedule for those drugs. The results of the study appeared in the May 2011 issue of the journal Clinical Therapeutics (paid subscription required). Poor medication adherence leads…

  • Audion, Sanofi to Partner on Hearing Loss Therapies

    The French pharmaceutical company Sanofi and biotechnology company Audion Therapeutics in Amsterdam have agreed to develop potential treatments for hearing loss through through regenerative medicine and biologics. The collaboration will build on technology developed by Audion’s co-founder Albert Edge at the Massachusetts Eye and Ear Infirmary in Boston. Audion originally licensed Edge’s technology from Mass…

  • Netherlands to Open Bio-Solar Research, Production Center

    The Netherlands begins on 17 June its BioSolar Cells research program to strengthen the science behind the sustainable production of bio-energy and food through photosynthesis. Also on 17 June, Wageningen University and Research Centre in the Netherlands opens its Algae Production and Research Centre (AlgaePARC), a production-scale lab to raise the output from algae bio-reactors…

  • FDA Approves Genetic Test for Breast Cancer Treatment

    The Food and Drug Administration (FDA) approved a new genetic test that will help health care professionals determine if women with breast cancer are candidates for Herceptin (trastuzumab), a commonly used breast cancer treatment. The Inform Dual ISH test is made by Ventana Medical Systems, a division of the Roche Group, in Tucson, Arizona. The…

  • Self-Repairing Structural Stress Sensor Developed

    A research team at North Carolina State University in Raleigh has built a sensor to measure the strain in structural materials and that can fix itself if broken. NCSU mechanical engineering student Young Song and faculty member Kara Peters published their findings in the June issue of the journal Smart Materials And Structures (paid subscription…

  • Wireless Security Devised for Implanted Medical Devices

    Engineers at Massachusetts Institute of Technology in Cambridge and University of Massachusetts in Amherst have designed a system that shields implanted medical devices like heart pacemakers and defibrillators from unauthorized wireless access or sabotage. Their findings will be presented at the ACM Special Interest Group on Data Communication (SIGCOMM) conference in Toronto, Canada in August.…

  • Lab Tests Indicate Inhaled Carbon Nanotubes Pose Cancer Risk

    Researchers at University of Edinburgh in Scotland found some types carbon nanotubes could cause cancer if inhaled. Ken Donaldson, a toxicology professor at Edinburgh, and colleagues published their findings in the June 2011 issue of the American Journal of Pathology (paid subscription required). Carbon nanotubes are a type of nanoscale material (1 nanometer equals 1…

  • 150+ Organizations Call for End to USPTO Fee Diversion

    Some 154 organizations sent a letter yesterday asking the House of Representatives leadership to preserve a section in the proposed patent reform legislation that lets the U.S. Patent and Trademark Office use collected patent fees to fund its operations. The organizations — representing companies, universities, and not-for-profit groups — sent the letter to Speaker of…

  • NIH Adds Five Clinical/Translational Research Centers

    National Institutes of Health says it will provide $200 million to five U.S. health research centers to speed scientific discoveries into treatments for patients. The five-year grants are part of the Clinical and Translational Science Awards (CTSA) program, under the National Center for Research Resources (NCRR) at NIH. CTSAs are now located at 60 institutions…